+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

  • ID: 5118597
  • Report
  • February 2021
  • Region: Global
  • GMD Research

FEATURED COMPANIES

  • AbbVie Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline plc
  • Lupin Limited
  • MORE
Global active pharmaceutical ingredients (API) market will reach $313.6 billion by 2027, growing by a revised 2020-2027 CAGR of 7.1% owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.



Highlighted with 150 tables and 101 figures, this 223-page report “Global Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Synthetic API
  • Branded Synthetic API
  • Generic Synthetic API
Biotech API by Drug Type:
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs
Biotech API by Customer Base:
  • Innovative Biologic API
  • Generic Biosimilar API
Biotech API by Expression Technology:
  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies
HPAPI
  • Branded HPAPI
  • Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

Captive Manufacturing
  • Branded Captive API
  • Generic Captive API
Merchant Manufacturing by Drug Type:
  • Branded Merchant API
  • Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
  • Merchant Synthetic API
  • Merchant Biotech API
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global API market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline plc
  • Lupin Limited
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Global Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Customer Base
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI

4 Segmentation of Global Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API

5 Segmentation of Global Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications

6 Segmentation of Global Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs

7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2020-2027
7.2 North America Market 2020-2027 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2020-2027 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2020-2027 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2020-2027 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 Rest of World Market 2020-2027 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market
Table 5. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 6. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2017-2027, $ bn
Table 7. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2017-2027, $ bn
Table 8. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2017-2027, $ bn
Table 9. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2017-2027, $ bn
Table 10. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2017-2027, $ bn
Table 11. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2017-2027, $ bn
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2017-2027, $ bn
Table 14. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2017-2027, $ bn
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 16. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2017-2027, $ bn
Table 17. Global Active Pharmaceutical Ingredients (API) Market by Region, 2017-2027, $ bn
Table 18. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 19. Leading National Active Pharmaceutical Ingredients (API) Market, 2020 and 2027, $ bn
Table 20. North America Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 21. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 22. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 23. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 24. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 25. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 26. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 27. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 28. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 29. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 30. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 31. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 32. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 33. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 34. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 35. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 36. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 37. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 38. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 39. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 40. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 41. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 42. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 43. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 44. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 45. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 46. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 47. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 48. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 49. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2017-2027, $ bn
Table 50. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 51. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 52. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 53. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 54. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 55. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 56. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 57. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 58. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 59. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 60. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 61. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 62. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 63. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 64. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 65. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 66. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2017-2027, $ bn
Table 67. South America Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 68. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 69. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 70. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 71. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 72. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 73. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 74. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 75. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 76. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 77. RoW Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn
Table 78. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 79. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 80. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 81. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 82. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 83. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 84. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn
Table 85. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn
Table 86. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn
Table 87. AbbVie Inc.: Company Snapshot
Table 88. AbbVie Inc.: Product Portfolio
Table 89. AbbVie Inc.: Revenue, 2017-2019, $ bn
Table 90. Astrazeneca: Company Snapshot
Table 91. Astrazeneca: Revenue, 2017-2019, $ bn
Table 92. Aurobindo Pharma Ltd.: Company Snapshot
Table 93. Aurobindo Pharma Ltd.: Product Portfolio
Table 94. Aurobindo Pharma Ltd.: Revenue, 2016-2020, $ INR million
Table 95. BASF: Company Snapshot
Table 96. BASF: Business Segmentation
Table 97. BASF: Revenue, 2016-2018, Euro million
Table 98. Bayer AG: Company Snapshot
Table 99. Bayer AG: Business Segmentation
Table 100. Bayer AG: Revenue, 2016-2018, € bn
Table 101. Bayer AG: Recent Developments
Table 102. Boehringer Ingelheim: Company Snapshot
Table 103. Boehringer Ingelheim: Business Segmentation in 2019
Table 104. Boehringer Ingelheim: Product Portfolio
Table 105. Boehringer Ingelheim: Revenue, 2017-2019, EUR million
Table 106. Boehringer Ingelheim: Revenue by Region in 2019
Table 107. Boehringer Ingelheim: Recent Developments
Table 108. Dr. Reddy's Laboratories: Company Snapshot
Table 109. Dr. Reddy's Laboratories: Business Segmentation
Table 110. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn
Table 111. F. Hoffmann-La Roche: Company Snapshot
Table 112. AbbVie Inc.: Business Segmentation
Table 113. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn
Table 114. GlaxoSmithKline: Company Snapshot
Table 115. GlaxoSmithKline: Business Segmentation
Table 116. GlaxoSmithKline: Product Portfolio
Table 117. GlaxoSmithKline: Revenue, 2016-2018, $ bn
Table 118. GlaxoSmithKline: Recent Developments
Table 119. Lonza Group: Company Snapshot
Table 120. Lonza Group: Business Segmentation in 2018
Table 121. Lonza Group: Product Portfolio
Table 122. Lonza Group: Revenue, 2017-2019, $ billion
Table 123. Lonza Group: Revenue by Region in 2018
Table 124. Lonza Group: Recent Developments
Table 125. Lupin Limited: Company Snapshot
Table 126. Lupin Limited: Business Segmentation
Table 127. Lupin Limited: Revenue, 2016-2018, INR billion
Table 128. Merck & Co., Inc.: Company Snapshot
Table 129. Merck & Co., Inc.: Business Segmentation
Table 130. Merck & Co., Inc.: Revenue, 2017-2019, $ bn
Table 131. Mylan NV: Company Snapshot
Table 132. Mylan NV: Revenue, 2017-2019, $ bn
Table 133. Novartis International AG: Company Snapshot
Table 134. Novartis International AG: Business Segmentation
Table 135. Novartis International AG: Revenue, 2017-2019, $ bn
Table 136. Pfizer Inc.: Company Snapshot
Table 137. Pfizer Inc.: Business Segmentation
Table 138. Pfizer Inc.: Product Portfolio
Table 139. Pfizer Inc.: Revenue, 2016-2018, $ bn
Table 140. Pfizer Inc.: Recent Developments
Table 141. Sanofi: Company Snapshot
Table 142. Sanofi: Business Segmentation
Table 143. Sanofi: Revenue, 2017-2019, $ bn
Table 144. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 145. Sun Pharmaceutical Industries Limited: Revenue, 2017-2019, INR bn
Table 146. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 147. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 148. Teva Pharmaceutical Industries Ltd.: Revenue, 2017-2019, $ bn
Table 149. Risk Evaluation for Investing in Global Market, 2020-2027
Table 150. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 5. Global Active Pharmaceutical Ingredients (API) Market, 2020-2027, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 8. GDP per capita in the World, 1960-2018, $ thousand
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market
Figure 13. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2020-2027, % of Revenue
Figure 14. Contribution to Global 2021-2027 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 15. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2017-2027, $ bn
Figure 16. Global Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2017-2027, $ bn
Figure 17. Global Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2017-2027, $ bn
Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Biotech API, 2017-2027, $ bn
Figure 19. Global Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2017-2027, $ bn
Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2017-2027, $ bn
Figure 21. Global Active Pharmaceutical Ingredients (API) Market: Vaccines, 2017-2027, $ bn
Figure 22. Global Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2017-2027, $ bn
Figure 23. Global Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2017-2027, $ bn
Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2017-2027, $ bn
Figure 25. Global Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2017-2027, $ bn
Figure 26. Global Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2017-2027, $ bn
Figure 27. Global Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2017-2027, $ bn
Figure 28. Global Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2017-2027, $ bn
Figure 29. Global Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2017-2027, $ bn
Figure 30. Global Active Pharmaceutical Ingredients (API) Market: HPAPI, 2017-2027, $ bn
Figure 31. Global Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2017-2027, $ bn
Figure 32. Global Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2017-2027, $ bn
Figure 33. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2020-2027, % of Revenue
Figure 34. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 35. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2017-2027, $ bn
Figure 36. Global Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2017-2027, $ bn
Figure 37. Global Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2017-2027, $ bn
Figure 38. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2017-2027, $ bn
Figure 39. Global Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2017-2027, $ bn
Figure 40. Global Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2017-2027, $ bn
Figure 41. Global Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2017-2027, $ bn
Figure 42. Global Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2017-2027, $ bn
Figure 43. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2020-2027, % of Revenue
Figure 44. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 45. Global Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2017-2027, $ bn
Figure 46. Global Active Pharmaceutical Ingredients (API) Market: Oncology, 2017-2027, $ bn
Figure 47. Global Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2017-2027, $ bn
Figure 48. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2017-2027, $ bn
Figure 49. Global Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2017-2027, $ bn
Figure 50. Global Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2017-2027, $ bn
Figure 51. Global Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2017-2027, $ bn
Figure 52. Global Active Pharmaceutical Ingredients (API) Market: Other Applications, 2017-2027, $ bn
Figure 53. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2020-2027, % of Revenue
Figure 54. Contribution to Global 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 55. Global Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2017-2027, $ bn
Figure 56. Global Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2017-2027, $ bn
Figure 57. Global Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2017-2027, $ bn
Figure 58. Global Market Snapshot by Region
Figure 59. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2020-2027, % of Revenue
Figure 60. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 61. Health Spending as a Share of GDP by Country, 2017 and 2030
Figure 62. North American Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 63. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 64. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 65. U.S. Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 66. Canada Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 67. Active Pharmaceutical Ingredients (API) Market in Mexico, 2017-2027, $ bn
Figure 68. European Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 69. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 70. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 71. Active Pharmaceutical Ingredients (API) Market in UK, 2017-2027, $ bn
Figure 72. Active Pharmaceutical Ingredients (API) Market in France, 2017-2027, $ bn
Figure 73. Active Pharmaceutical Ingredients (API) Market in Germany, 2017-2027, $ bn
Figure 74. Active Pharmaceutical Ingredients (API) Market in Spain, 2017-2027, $ bn
Figure 75. Active Pharmaceutical Ingredients (API) Market in Italy, 2017-2027, $ bn
Figure 76. Active Pharmaceutical Ingredients (API) Market in Russia, 2017-2027, $ bn
Figure 77. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2017-2027, $ bn
Figure 78. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 79. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 80. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 81. Active Pharmaceutical Ingredients (API) Market in China, 2017-2027, $ bn
Figure 82. Active Pharmaceutical Ingredients (API) Market in Japan, 2017-2027, $ bn
Figure 83. Active Pharmaceutical Ingredients (API) Market in India, 2017-2027, $ bn
Figure 84. Active Pharmaceutical Ingredients (API) Market in Australia, 2017-2027, $ bn
Figure 85. Active Pharmaceutical Ingredients (API) Market in South Korea, 2017-2027, $ bn
Figure 86. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2017-2027, $ bn
Figure 87. South America Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn
Figure 88. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 89. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 90. Active Pharmaceutical Ingredients (API) Market in Argentina, 2017-2027, $ bn
Figure 91. Active Pharmaceutical Ingredients (API) Market in Brazil, 2017-2027, $ bn
Figure 92. Active Pharmaceutical Ingredients (API) Market in Chile, 2017-2027, $ bn
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2017-2027, $ bn
Figure 94. Active Pharmaceutical Ingredients (API) Market in Rest of the World (RoW), 2017-2027, $ bn
Figure 95. Breakdown of RoW Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue
Figure 96. Contribution to RoW 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 97. Active Pharmaceutical Ingredients (API) Market in UAE, 2017-2027, $ bn
Figure 98. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2017-2027, $ bn
Figure 99. Active Pharmaceutical Ingredients (API) Market in South Africa, 2017-2027, $ bn
Figure 100. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 101. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll